Fig. 2From: The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humansTransaxial images (top PET, bottom PET/CT fused images) across the a heart, b kidneys, and c liver/spleen from the same subject 135 presented in Fig. 1. Times post dose 7, 79, 120, and 168 h post dose. Additional transaxial images for additional subjects 105 and 127 are provided in the Additional file 1: Figures S3 and S5Back to article page